SynthesisBMC cancer2019

Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation.

Kazuhiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.